WebApr 11, 2024 · 1 292. Free-Float. 44,5%. More Financials. Company. Ginkgo Bioworks Holdings, Inc. provides horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. WebMar 7, 2024 · Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Get Rating) gapped down before the market opened on Monday after BTIG Research lowered their price target on the stock from $4.00 to $3.00 ...
Ginkgo Bioworks downgraded at BofA with price target cut to half
WebApr 13, 2024 · According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $4.39. Ginkgo Bioworks Company Profile . Ginkgo Bioworks Holdings, Inc, together ... WebApr 11, 2024 · The Ginkgo Bioworks stock price fell by -0.741% on the last day (Tuesday, 11th Apr 2024) from $1.35 to $1.34.During the last trading day the stock fluctuated 7.63% from a day low at $1.31 to a day high of $1.41.The price has fallen in 6 of the last 10 days but is still up by 8.94% over the past 2 weeks. Volume has increased on the last day by 2 … has archer ended
BofA Downgrades Ginkgo Bioworks, Cuts Price Target In Half
WebMay 18, 2024 · The Ginkgo Bioworks Analyst: Derik de Bruin downgraded the rating for Ginkgo Bioworks from Neutral to Underperform, while reducing the price target from … WebSep 21, 2024 · Initiating coverage on Ginkgo Bioworks, Sriharsha Pappu, an HSBC analyst, assigned a buy rating on the stock and a $14 price target. According to … WebJul 16, 2024 · Bill Gates, Cathie Wood, and John Doerr are among the backers. Here are three stocks to bet on the future. has archie died yet